GSK reports Shingrix (Recombinant Zoster Vaccine) phase IV study of 6000 persons >50 yrs in China(ZOSTER-076). NO SHI
Tweet Content
GSK reports Shingrix (Recombinant Zoster Vaccine) phase IV study of 6000 persons >50 yrs in China(ZOSTER-076). NO SHINGLES cases reported in those who received RZV, vs 31 HZ cases on placebo. Confirms (or is better) results of ZOE50 & ZOE70 RCTs https://t.co/kOZfgpQ0PX https://t.co/5t9cHM5ioS
Show on Archive Page
On
Display in Search Results
On
PDQ
Off